Iqvia Holdings IQV
NYSE IQV
$269.47 +0.65 (+0.24%)
As of: Sep 17, 2026 · 3:59 PM EDT

Iqvia Holdings (IQV) Non-Current Deferred Tax Liability (2011 - 2026)

Iqvia Holdings' (IQV) quarterly Non-Current Deferred Tax Liability came in at $173.0 million in Q2 2026, down 19.91% year-over-year from $216.0 million in Q2 2025, and up 8.81% quarter-over-quarter from $159.0 million in Q1 2026.

Analysis

Iqvia Holdings (IQV) Non-Current Deferred Tax Liability (2011 - 2026) Analysis & Trends

Iqvia Holdings has disclosed Non-Current Deferred Tax Liability across 16 years of filings, most recently posting $173.0 million for Q2 2026.

  • In Q2 2026, Non-Current Deferred Tax Liability fell 19.91% year-over-year to $173.0 million; the TTM figure through Jun 2026 stood at $173.0 million (down 19.91% YoY), while the FY2025 annual figure was $179.0 million, down 75.78% from the prior year.
  • Non-Current Deferred Tax Liability came in at $173.0 million for Q2 2026 at Iqvia Holdings, up from $159.0 million in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $976.0 million in Q4 2022 to a low of $128.0 million in Q3 2024.
  • Average Non-Current Deferred Tax Liability over 5 years is $373.1 million, with a median of $290.5 million recorded in 2023.
  • Year-over-year, Non-Current Deferred Tax Liability surged 88.55% in 2022 and slumped 75.78% in 2025.
  • Over 5 years, Non-Current Deferred Tax Liability stood at $976.0 million in 2022, then decreased by 21.52% to $766.0 million in 2023, then decreased by 3.52% to $739.0 million in 2024, then tumbled by 75.78% to $179.0 million in 2025, then dropped by 3.35% to $173.0 million in 2026.
  • Per Business Quant data, the three most recent Non-Current Deferred Tax Liability figures were $173.0 million in Q2 2026, $159.0 million in Q1 2026, and $179.0 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn
6 Evotec SE 574.75 Mn 148.87 Mn -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 173.00 Mn
Mar 31, 2026 159.00 Mn
Dec 31, 2025 179.00 Mn
Sep 30, 2025 207.00 Mn
Jun 30, 2025 216.00 Mn
Mar 31, 2025 197.00 Mn
Dec 31, 2024 739.00 Mn
Sep 30, 2024 128.00 Mn
Jun 30, 2024 149.00 Mn
Mar 31, 2024 164.00 Mn
Dec 31, 2023 766.00 Mn
Sep 30, 2023 365.00 Mn
Jun 30, 2023 367.00 Mn
Mar 31, 2023 421.00 Mn
Dec 31, 2022 976.00 Mn
Sep 30, 2022 560.00 Mn
Jun 30, 2022 494.00 Mn
Mar 31, 2022 455.00 Mn
Dec 31, 2021 1.07 Bn
Sep 30, 2021 297.00 Mn